The life expectancy of patients with GSD1a has been improved by introducing strict dietary management as the standard of care, but these patients still face life-threatening hypoglycemia, metabolic abnormalities, and the risk of HCA/HCC (3, 4). This evidence concerns the gene G6PC1 and Hypoglycemia.